Informações:
Falhas:
ID
16451
Descrição
Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01695226
Link
https://clinicaltrials.gov/show/NCT01695226
Palavras-chave
Versões (1)
- 17/07/2016 17/07/2016 -
Transferido a
17 de julho de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Breast Neoplasms NCT01695226
Eligibility Breast Neoplasms NCT01695226
- StudyEvent: Eligibility
Similar models
Eligibility Breast Neoplasms NCT01695226
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
invasive breast cancer, indication for biopsy
Item
female patients suspected of having invasive breast cancer, >1 cm in diameter, and in whom there is an indication for a core or incision biopsy
boolean
C0853879 (UMLS CUI [1])
C0392360 (UMLS CUI [2,1])
C0405352 (UMLS CUI [2,2])
C0392360 (UMLS CUI [2,1])
C0405352 (UMLS CUI [2,2])
Age
Item
age <75 years at time of diagnosis
boolean
C0001779 (UMLS CUI [1])
Compliance
Item
patient willing and able to comply with the study prescriptions
boolean
C1321605 (UMLS CUI [1])
Written consent
Item
patient able to give written informed consent before patient registration/randomisation
boolean
C0021430 (UMLS CUI [1])
Menopausal state
Item
pre- and post-menopausal patients are eligible
boolean
C0025320 (UMLS CUI [1])
Hormone receptor status
Item
hormone receptor positive and negative patients are eligible
boolean
C1562029 (UMLS CUI [1])
C2584453 (UMLS CUI [2])
C2584453 (UMLS CUI [2])
a negative pregnancy test in pre-menopausal women
Item
a negative pregnancy test in pre-menopausal women
boolean
C0427780 (UMLS CUI [1,1])
C0232969 (UMLS CUI [1,2])
C0232969 (UMLS CUI [1,2])
hiv, hbv or hcv positivity
Item
hiv, hbv or hcv positivity
boolean
C0019699 (UMLS CUI [1])
C0856706 (UMLS CUI [2])
C1112419 (UMLS CUI [3])
C0856706 (UMLS CUI [2])
C1112419 (UMLS CUI [3])
hypersensitivity to nsaids
Item
known hypersensitivity to nsaids
boolean
C0020517 (UMLS CUI [1,1])
C0003211 (UMLS CUI [1,2])
C0003211 (UMLS CUI [1,2])
upper gastro-intestinal bleeding
Item
a history of upper gastro-intestinal bleeding
boolean
C0041909 (UMLS CUI [1])
upper gastro-intestinal ulceration
Item
endoscopically proven upper gastro-intestinal ulceration
boolean
C0030920 (UMLS CUI [1,1])
C3203348 (UMLS CUI [1,2])
C3203348 (UMLS CUI [1,2])
nsaids
Item
patients using nsaids, including salicyclic acid
boolean
C0003211 (UMLS CUI [1])
systemic corticosteroids
Item
systemic use of corticosteroids
boolean
C2825233 (UMLS CUI [1])
other malignancy
Item
a history or the presence of any other malignancy excepting adequately treated squamous cell skin cancer or in situ carcinoma of the cervix
boolean
C0006826 (UMLS CUI [1])
C0009488 (UMLS CUI [2])
C0009488 (UMLS CUI [2])
neo-adjuvant chemotherapy or hormone therapy
Item
patients who have been treated with neo-adjuvant chemotherapy or hormone therapy
boolean
C3665472 (UMLS CUI [1,1])
C0600558 (UMLS CUI [1,2])
C0279025 (UMLS CUI [2])
C0600558 (UMLS CUI [1,2])
C0279025 (UMLS CUI [2])